Multiple sclerosis: Imaging, diagnostic criteria and differential diagnosis;Bildgebung, diagnosekriterien und differenzial-diagnose der multiplen sklerose

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 175, Issue 5, 2003, Pages 613-622

  Harting, I ^a   Sellner, J ^a   Meyding Lamade U ^a   Sartor, K ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Demyelination; Inflammatory CNS diseases; MRI; Multiple sclerosis

Indexed keywords

N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

BEHCET DISEASE; CLINICAL EXAMINATION; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GLIOSIS; HUMAN; IMAGE ANALYSIS; LEUKOENCEPHALOPATHY; LYMPHOMA; MULTIPLE SCLEROSIS; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBEROUS SCLEROSIS; BRAIN; DIFFUSION WEIGHTED IMAGING; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; MYELINATED NERVE; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REPRODUCIBILITY; SPINAL CORD;

ASPARTIC ACID; AXONS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; REPRODUCIBILITY OF RESULTS; SPINAL CORD;

EID: 0037526634     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39198     Document Type: Review

References (51)

1. Kurtzke J. The epidemiology of multiple sclerosis. In: Raine C, McFarland H, Tourtellotte W (eds). Chapman & Hall, 1997: 91-139
2. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group (see comments). Nature 1995; 377: 150-151
3. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-952
4. Kieseier BC, Storch MK, Archelos JJ, Martino G, Hartung HP. Effector pathways in immune mediated central nervous system demyelination. Curr Opin Neurol 1999; 12: 343-336
5. van der Knaap MS, Valk J. Magnetic resonance of myelin, myelination, and myelin disorders. 2nd edition. Berlin, Heidelberg, New York: Springer, 1995
6. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogenity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717
7. Weinshenker B. The natural history of multiple sclerosis. Neurol Clin 1995; 13: 119-146
8. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. 2. Predictive value of the early clinical course. Brain 1989; 112: 133-146: 1419-1428
9. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185
10. Ormerod IE, Miller DH, McDonald WI, du Boulay EP, Rudge P, Kendall BE, Moseley IF, Johnson G, Tofts PS, Halliday AM, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987; 110: 1579-1616
11. Fog T. The topography of plaques in multiple sclerosis. Acta Neurol Scand 1965; 15: 1-161
12. Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM, Davis KR. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991; 180: 215-221
13. Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989; 25: 43-49
14. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-793
15. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Brück W. A longitudinal MRI study of histophathology defined hypointense multiple sclerosis. Ann Neurol 2001; 49: 793-796
16. 1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282-1288
17. Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs. clinical findings in determining disease activity. Am J Roentgenol 1992; 159: 1041-1047
18. He J, Grossman RI, Ge Y, Mannon LJ. Enhancing patterns in multiple sclerosis: evolution and persistence. Am J Neuroradiol 2001; 22: 664-669
19. Lai M, Hodgson T, Gawne-Cain M, Webb S, MacManus D, McDonald WI, Thompson AJ, Miller DH. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psych 1996; 60: 339-341
20. Goodkin DE, Rooney WD, Sloan R, Bacchetti P, Gee L, Vermathen M, Waubant E, Abundo M, Majumdar S, Nelson S, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998; 51: 1689-1697
21. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999; 52: 1626-1632
22. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809-814
23. O'Riordan JI, Thompson AJ, Kingsley DPE, MacManus DG, Kendall BE, Rudge P, McDonald WI, Miller DH. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998; 121: 495-503
24. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, McDonald WI, Miller DH. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993; 43: 2632-2637
25. Lycklama a' Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, Van Waesberghe JH, Polman C, Jongen SJ, Valk J. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. Am J Neuroradiol 1997; 18: 1041-1048
26. Thorpe JW, Kidd D, Kendall BE, Tofts PS, Barker GJ, Thompson AJ, MacManus DG, McDonald WI, Miller DH. Spinal cord MRI using multiarray coils and fast spin echo. 1. Technical aspects and findings in healthy adults. Neurology 1993; 43: 2625-2631
27. Yetkin FZ, Haughton VM, Papke RA, Fischer ME, Rao SM. Multiple sclerosis: specificity of MR for diagnosis. Radiology 1991; 178: 447-451
28. Thorpe JW, Kidd D, Moseley IF, Kenndall BE, Thompson AJ, MacManus DG, McDonald WI, Miller DH. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 1996; 46: 373-378
29. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.36 (z. B. Arnold 1990)
30. DeStefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol, 2001
31. Matthews PM, De Stefano N, Narayanan S, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998; 18: 327-336
32. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama A, Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhos F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-754
33. 1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999; 46: 79-87
34. Simon JH, Jacobs L, Kinkel RP. Transcallosal bands: A sign of neuronal tract degeneration in early MS? Neurology 2001; 57: 1888-1890
35. Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999; 53: 1698-1704
36. Chard DT, Griffin CM, Parker GJM, Kapoor R, Thompson AJ, Miller DH. Brain atrophy in early relapsing-remitting multiple sclerosis. Brain 2002; 125: 327-337
37. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391-395
38. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999; 122 (Pt 10): 1933-1939
39. Guo AC, Jewells VL, Provenzale JM. Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. Am J Neuroradiol 2001; 22: 1893-1900
40. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995; 196: 511-515
41. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979; 41: 81-91
42. 2-weighted dual spin echo. Neurology 1997; 49: 364-370
43. Schumacher G, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in multiple sclerosis: report of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965; 122: 552-568
44. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KB, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 231-239
45. Barkhof F, Filippi M, Miller D, Scheltens P, Campi A, Polman C. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069
46. Tintoré M, Rovira A, Martinez M, Rio J, Diaz-Villoslada P, Brieva L. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702-706
47. McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F, McFarland H, Paty D, Polman C, Reingold S, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127
48. Choi KH, Lee KS, Chung SO, Park JM, Kim YJ, Kim HS, Shinn KS. Idiopathic transverse myelitis: MR characteristics. Am J Neuroradiol 1996; 18: 1151-1160
49. Scolding N. The differential diagnosis of multiple sclerosis. J Neurol Neurosurg Psych 2001; 71: 119-115
50. Dichgans M, Gasser T. CADASIL: Klinische Aspekte und Diagnose. Dtsch Med Wochenschr 1998; 123: 979-981
51. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up of 40 adult patients. Neurology 2001; 56: 1313-1318